Pierre Fabre Laboratories has acquired a minority stake in MiYé, a French company specializing in skincare products and dietary supplements dedicated to women’s hormonal balance and well-being.
This first capital increase will enable MiYé to ramp up its development by benefiting from Pierre Fabre Laboratories’ medical expertise and in-depth knowledge of the pharmacy market.
MiYé, is a brand created by women for women, to help them live better with their hormonal fluctuations and improve their quality of life, from puberty to menopause. Co-founded by Caroline de Blignières and Anna Oualid, with the support of a scientific committee specialized in the endocrine system, MiYé has opted to focus on the hormonal well-being market.
The brand’s innovative and disruptive approach addresses the underlying causes of the often taboo and misunderstood symptoms of hormonal imbalance. MiYé currently offers a comprehensive range of 13 products, (5 dietary supplements and 8 dermo-cosmetics) centered on performance, naturalness, safety and ease of use.
With a history dating back to 1962, Pierre Fabre Laboratories has been actively involved in women’s health via a comprehensive portfolio of medicinal and dermo-cosmetics products. Through their investment subsidiary Pierre Fabre Invest, they pursue a strategy of acquiring stakes in fast-growing start-ups whose positioning complements their established dermo-cosmetics brands.
Pierre Fabre Invest became the majority shareholder in Ladrôme Laboratoire (specializing in organic skincare and cosmetics) in 2021, and the sole shareholder in Même Cosmetics (specializing in wellness treatments for cancer patients) in 2022. With this investment, it becomes MiYé’s sole minority shareholder alongside the two co-founders.
